1. Home
  2. GDTC vs SCOR Comparison

GDTC vs SCOR Comparison

Compare GDTC & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • SCOR
  • Stock Information
  • Founded
  • GDTC 2018
  • SCOR 1999
  • Country
  • GDTC Singapore
  • SCOR United States
  • Employees
  • GDTC N/A
  • SCOR N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • SCOR Business Services
  • Sector
  • GDTC Health Care
  • SCOR Consumer Discretionary
  • Exchange
  • GDTC Nasdaq
  • SCOR Nasdaq
  • Market Cap
  • GDTC 29.4M
  • SCOR 29.0M
  • IPO Year
  • GDTC 2023
  • SCOR 2007
  • Fundamental
  • Price
  • GDTC $2.23
  • SCOR $6.38
  • Analyst Decision
  • GDTC Buy
  • SCOR Buy
  • Analyst Count
  • GDTC 1
  • SCOR 2
  • Target Price
  • GDTC $5.00
  • SCOR $10.75
  • AVG Volume (30 Days)
  • GDTC 15.9K
  • SCOR 11.8K
  • Earning Date
  • GDTC 01-01-0001
  • SCOR 05-06-2025
  • Dividend Yield
  • GDTC N/A
  • SCOR N/A
  • EPS Growth
  • GDTC N/A
  • SCOR N/A
  • EPS
  • GDTC N/A
  • SCOR N/A
  • Revenue
  • GDTC $330,254.00
  • SCOR $356,047,000.00
  • Revenue This Year
  • GDTC $14.71
  • SCOR $4.38
  • Revenue Next Year
  • GDTC N/A
  • SCOR $3.97
  • P/E Ratio
  • GDTC N/A
  • SCOR N/A
  • Revenue Growth
  • GDTC N/A
  • SCOR N/A
  • 52 Week Low
  • GDTC $1.20
  • SCOR $4.89
  • 52 Week High
  • GDTC $4.05
  • SCOR $16.41
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 34.89
  • SCOR 46.46
  • Support Level
  • GDTC $1.98
  • SCOR $6.42
  • Resistance Level
  • GDTC $2.56
  • SCOR $7.02
  • Average True Range (ATR)
  • GDTC 0.18
  • SCOR 0.47
  • MACD
  • GDTC -0.04
  • SCOR 0.02
  • Stochastic Oscillator
  • GDTC 31.25
  • SCOR 30.77

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.

Share on Social Networks: